St. Jude Medical, Inc. (STJ) Tops Q2 EPS by 2c; Boosts FY13 EPS Outlook
Tweet Send to a Friend
St. Jude Medical, Inc. (NYSE: STJ) reported Q2 EPS of $0.96, $0.02 better than the analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
